Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Gynecologic Oncology Reports|July 9, 2020
Opsoclonus-ataxia syndrome and mature ovarian teratoma in an adolescentEmily M Webster, Joan Tymon-Rosario, Johanna D'Addario, et al.
Peptide Research|July 1, 1992
Chimeric enkephalin-cystatins: opioid binding and structure-activity relationships of inhibitory domainsN Marks, M J Berg, R C Makofske, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1990
Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complexA N Schoffelmeer, Y H Yao, T L Gioannini, et al.
Molecular Cancer Research : MCR|January 14, 2014
Triapine disrupts CtIP-mediated homologous recombination repair and sensitizes ovarian cancer cells to PARP and topoisomerase inhibitorsZ Ping Lin, Elena S Ratner, Margaret E Whicker, et al.
Scientific Reports|July 2, 2025
CXCL10-induced regulatory T cells and adenosine signaling promote immunosuppression and progression of epithelial ovarian cancerAnnabelle C Lin, Jake Moscarelli, Yong-Lian Zhu, et al.
BMC Cancer|July 29, 2016
MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparibMargaret E Whicker, Z Ping Lin, Ruth Hanna, et al.
Analytical Biochemistry|September 13, 2015
A simple and inexpensive method to control oxygen concentrations within physiological and neoplastic rangesP G Penketh, K Shyam, R P Baumann, et al.
Plos One|July 8, 2024
Predictive modeling of gene mutations for the survival outcomes of epithelial ovarian cancer patientsMirielle C Ma, Ethan S Lavi, Gary Altwerger, et al.
Cancers|August 12, 2023
Transforming Growth Factor Beta and Epithelial to Mesenchymal Transition Alter Homologous Recombination Repair Gene Expression and Sensitize BRCA Wild-Type Ovarian Cancer Cells to OlaparibCai M Roberts, Mehida Rojas-Alexandre, Ruth E Hanna, et al.
Brachytherapy|April 19, 2015
Predictors of vaginal stenosis after intravaginal high-dose-rate brachytherapy for endometrial carcinomaHenry S Park, Elena S Ratner, Laura Lucarelli, et al.
Pageof 9